Amyotrophic lateral sclerosis is a fatal disease caused by degeneration of motor neurons (MNs). We transplanted multipotent neural precursor cell (NPC)-neurospheres from mouse olfactory bulb (OB) into the spinal cord of transgenic mice that develop MN degeneration because of human mutant superoxide dismutase-1 (mSOD1). Adult NPCs were isolated from the OB core of transgenic mice expressing green fluorescent protein, human wild-type SOD1, or human mSOD1. mSOD1 mice received lumbar spinal cord transplants of OB-NPC neurospheres at preclinical stages of disease (70 days old). Control mSOD1 mice received dead cells or recombinant green fluorescent protein. OB-NPCs attenuated the loss of motor function and wasting. They delayed disease onset to~117 days, compared with control onset at~90 days. The lifespan of NPC recipient mice was extended (~170 days) compared with the lifespan of controls (~140 days). Transplanted OB-NPCs differentiated into large spinal neurons positive for choline acetyltransferase, interneurons, and glial cells. Loss of endogenous MNs was attenuated in mSOD1 mice with transplants. New neurons formed myelinated axons and synapses. NPC-derived neurons issued axons that grew into peripheral nerve. OB-NPCs also differentiated into oligodendrocytes and astrocytes that contacted neuronal processes. We conclude that transplantation of adult OB-NPCs is therapeutic for mouse amyotrophic lateral sclerosis.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal adultonset disease of motor neurons (MNs) in cerebral cortex, brainstem, and spinal cord (1Y3). Patients with ALS become paralyzed and generally die within 5 years after clinical onset and diagnosis. No effective therapies are available for patients with ALS (1) . Several neurotrophic factors have been tested in patients with ALS, but the success was insufficient to support their use clinically for disease treatment (3) . Riluzole, a Na + channel blocker with effects on glutamate release, is the only drug approved for the symptomatic treatment of ALS. In clinical trials the beneficial effects of riluzole in patients with ALS were marginal, and other drugs with glutamate antagonist actions are ineffective (1) .
Regenerative medicine through novel cell-based therapies (4) needs to be explored for treating ALS. Neural stem cells (NSCs) and other stem cell (SC) types could restore neurologic function in patients with ALS (5Y7). SCs can be derived from embryos and several adult tissues (4, 8) . To date, the transplantation of allogenic or xenogenic embryonic SCs or adult SCs as a therapy to treat MN disorders is experimental, and more data needs to be collected on animal models to determine beneficial or harmful effects of this approach. Existing animal studies of traumatically injured or diseased spinal cord with grafts of embryonic mouse SCs (9) , human embryonic germ cells (10) , human fetal NSCs (11) , human umbilical cord SCs (12, 13) , adult mouse bone marrow SCs (14) , or adult mouse multipotent neural precursor cells (NPCs) (15, 16) have demonstrated positive effects on behavioral or clinical outcome but very limited or no evidence for differentiation of grafted cells into cells with MN-like characteristics. In contrast, adult NPCs from the olfactory bulb (OB) core (17Y19) can adopt phenotypes of MNs in vitro and in an animal model of axotomy-induced MN degeneration (20) . The OB of adult rat, mouse, and human contains multipotent (stem) NPCs (17Y21). The OB core is part of the anterior subventricular zone (SVZ)-rostral migratory stream system of NPCs (22) . Because the OB core is the rostral extension of the SVZ, the NPCs within this structure are more accessible than those in the SVZ, lying deep within the forebrain, for potential experimental autologous transplantation. Thus, the OB could be of major importance to neuroregenerative medicine if proof of principle is further established that the OB core contains NPCs that are useful for transplantation in animal models of neurodegenerative disease. Studies evaluating the ability of adult OB-NPCs to alter the course of disease in genetic models of ALS have not been performed. This study, originally presented partly in abstract form (23) , demonstrates the therapeutic benefits of transplanted adult OBNPCs in a human mutant superoxide dismutase-1 (mSOD1) transgenic mouse model of ALS.
MATERIALS AND METHODS

Animals
Adult male transgenic (tg) mice expressing human mSOD1 were used to test the therapeutic benefit of transplanted adult OB-NPCs. The mSOD1 mice expressed the form of human SOD1 containing the Gly39YAla (G39A) substitution mutation (24, 25) . A line (B6SJL-TgN[SOD1-G93A]1Gur) with a high copy number of mutant allele and a rapid disease onset was used (The Jackson Laboratory, Bar Harbor, ME). Hemizygous tg mice develop symptoms at about 11 to 13 weeks of age and become profoundly paralyzed in all limbs and die at about 16 weeks of age and have severe degeneration of MNs in spinal cord (25) . The sources of adult NPCs used for transplantation were adult heterozygotic tg male mice ubiquitously expressing green fluorescent protein (GFP) driven by a A-actin promoter (C57BL/6-TgN[ACTbEGFP]1Osb, The Jackson Laboratory) (20) and adult tg mice expressing human mutant G93A or the wild-type (wt) SOD1 gene driven by the human SOD1 promoter (21) . Non-tg mice (C57BL/6), which contributed to the genetic background of the mSOD1 tg mice, were used as naive controls in motor function tests. For a positive control for the neuromuscular junction (NMJ) structural analysis, we used tg mice expressing yellow fluorescent protein (YFP) driven by a Thy-1 promoter (B6.Cg-Tg[Thy1-YFP]16Jrs/J, stock no. 003709; The Jackson Laboratory). These mice express YFP at high levels in MNs. The motor axons are brightly fluorescent entirely to the NMJ. The institutional animal care and use committee approved the protocols.
Isolation, Culture, and Lentiviral Transfection of OB Core NPCs
Neurosphere-forming cells were isolated from non-tg C57BL/6 mice (n = 12), GFP tg mice (n = 10), human G93A mSOD1 tg mice (n = 3), and human wtSOD1 tg mice (n = 3) as described (18Y21). The mice were 4 to 6 weeks of age at the time of NPC harvesting. The OB core, defined previously in detail (19) , was exposed by a midline sagittal incision and reflection of the 2 sides. From each side of exposed OB core~0.25 mm of tissue was microdissected discretely under a Zeiss surgical microscope and collected into wells containing Hanks_ balanced salt solution. This tissue sample contains primary cells and cells that possess features of NSCs and NPCs, including multipotency, selfrenewal, self-maintenance, expression of NSC and newborn neuron proteins, and responsiveness to NSC trophins such as fibroblast growth factor 2 (19Y21). The tissue was placed in 0.25% trypsin-EDTA and incubated (37-C, 5% CO 2 and 95% air) for 20 minutes followed by trituration to dissociate cells. Cells were seeded on poly-D-lysine-coated 35-mm well tissue culture plates at a density of 6 Â 10 5 /mL with Dulbecco_s minimal essential medium (DMEM) (Gibco/Life Technologies, Rockville, MD) containing high glucose, glutamine, fibroblast growth factor 2, B27 (Gibco), DNase I and antibiotics (100 U/mL penicillin and 100 Kg/mL streptomycin). After 24 hours the medium contains nonadherent floating clonal colonies of cells, neurospheres (26) , which are multipotent NPCs (19Y21). The evidence that the floating colonies of cells are neurospheres is derived from experiments demonstrating their ability to proliferate and generate a large number of progeny that can differentiate into the 3 primary neural cell types ( Fig. 1) (19, 21) .
Primary neurospheres were pelleted, resuspended, and dissociated by trypsin digestion and trituration. Cell suspensions were transferred to noncoated wells for further expansion of highly proliferating sphere-forming cells. After 9 passages of the original primary spheres, floating spheres were allowed to grow in poly-D-lysine coated 35-mm well plates in DMEM containing high glucose, glutamine, and supplemented with B27 and antibiotics. These spheres were diluted, by a limited dilution method, to isolate individual spheres and were transferred into individual wells with neurosphere growth medium for an additional passage. Neurospheres were then collected and cryopreserved in DMEM containing dimethyl sulfoxide and fetal bovine serum. Cryopreserved neurospheres were recovered later for transplantation.
Neurosphere-forming OB-NPCs isolated from mSOD1 and wtSOD1 tg mice were stably transfected with a GFP reporter gene using lentivirus, so that transplanted cells could be distinguished from mSOD1 tg host mice after transplantation. A lentiviral expression system for GFP was engineered using a ViraPower kit (Invitrogen, Carlsbad, CA). A lentiviral-based expression vector containing the GFP coding sequence, PLL3.7, and 3 other plasmids, pLP1, pLP2, and pLP/VSVG (Invitrogen) were cotransfected using Lipofectamine 2000 into 293FT producer cells (Invitrogen), after 3 passages, at a density of 1.2 Â 10 6 /mL in growth medium (without serum and antibiotics) in cell culture flasks. After 14 hours of incubation at 37-C, the medium containing Lipofectamine was removed and replaced with DMEM containing 10% fetal bovine serum, 2 mM L-glutamine, 0.1 mM minimal essential medium nonessential amino acids, 1% penicillin/streptomycin, and 1 mM minimal essential medium sodium pyruvate. Supernatants were harvested at 48 hours post-transfection by removing medium into 15-mL sterile tubes, which were then centrifuged at 3,000 rpm for 15 minutes at 4-C to pellet and remove cell debris. Viral particles were further purified and concentrated by centrifugation at 50,000 rpm. The pellets were resuspended in sterile PBS. Titering was done by transfecting 293FT cells with a series of concentrations of lentivirus preparations (mock and 10 j2 Y10 j6 dilutions in 6-well plates) and then counting cell colonies that were GFP + by fluorescence microscopy. OB-NPC neurospheres from wtSOD1 tg mice and mSOD1 tg mice were used for transfection after at least 9 passages (21). For OB-NPC transduction, 5 KL of 10 9 viral particles was added into each neural sphere culture well (in 35-mm wells with the same medium used for 293FT cell post-transfection culture). They were screened for GFP fluorescence after 48 hours (~68% spheres were green at 48 hours after exposure to lentivirus). Mock-transfected neurospheres did not have green fluorescence. The spheres were harvested by centrifugation at 900 rpm for 5 minutes and then were resuspended in PBS and were either transplanted into mSOD1 mouse spinal cord as described below or were cryopreserved.
Neurosphere Characterization
Mouse OB neurosphere multipotency was confirmed using single cell-derived neurospheres derived originally by limited dilution (1 cell/100 KL in wells of a 96-well plate) of dissociated primary neurosphere cells (20) . These neurospheres were allowed to attach to the culture plates and then were cultured for an additional 3 days. The attached neurosphere cultures were fixed with 4% paraformaldehyde (PF) and stained with antibodies to localize markers for astrocytes (GFAP), neurons (class II A-tubulin), and oligodendrocytes (the sulfatide O-antigen O4) as described (18Y21). The primary antibodies used were from commercial sources: mouse monoclonal anti-GFAP IgG (Roche Diagnostics, Indianapolis, IN), rabbit polyclonal anti-GFAP IgG (Dako, Carpinteria, CA), rabbit polyclonal anti-class II A-tubulin IgG (TuJ1 antibody; Covance, Richmond, CA), and mouse monoclonal anti-O4 IgM (Chemicon International, Temecula, CA). Secondary antibodies or avidin (Invitrogen) were conjugated to Alexa 488 (green), Texas Red (red), or Cascade Blue (blue). Triple labeling was done using primary antibodies from different species of animals or different immunoglobulin subtypes. Controls for antibody specificity were performed for each antibody by incubating cultures in the primary antibody diluent without primary antibody with all other steps similar.
Transplantation of Adult OB-NPCs into ALS Mouse Spinal Cord
OB-NPC neurospheres from adult GFP tg mice, human wtSOD1 tg mice, and human mSOD1 tg mice were used for transplantation into mSOD1 mice. The OB-NPC neurospheres, derived from at least passage 9 neurospheres derived from progeny of single cells of primary neurospheres, were recovered from cryopreservation and expanded over 2 to 3 days or were used immediately after lentiviral transfection. They were pelleted gently by centrifugation and resuspended and washed with DMEM. mSOD1 mice received lumbar spinal cord transplants of GFP tg OB-NPC neurospheres (n = 27 mice) at preclinical + cell with a splayed cytoplasm and globular processes typical of an immature oligodendrocyte. Right inset in D shows a more mature oligodendrocyte with O4 staining decorating the surface of the cell body and its long thin processes. For this experiment the neurospheres were kept small and analyzed soon after attachment to show that the cells analyzed still are grouped in the general shape of a flattening sphere and are not in a completely dispersed monolayer, at which time it is difficult to show that the cells under study were indeed sphere-derived. Scale bar = (in B for A) 10 Km; (in B for BY YD) 25 Km.
stages of the disease (70 days of age). Two additional cohorts of mSOD1 mice received lumbar spinal cord transplants of wtSOD1 tg OB-NPC neurospheres (n = 16 mice) or mSOD1 tg OB-NPC neurospheres (n = 16 mice) at preclinical stages of the disease (70 days of age). Aseptic surgical procedures were used. The mice were deeply anesthetized (enflurane/oxygen/nitrous oxide, 1:66:33), and the surgical area in the lumbar region of the back was shaved and disinfected. The mice were mounted in a stereotaxic apparatus (Stoelting) with a nosepiece to continuously deliver gas anesthesia. With the aid of a Zeiss surgical microscope, windows in the lumbar region of the vertebral column were created by dorsal laminectomy. Cell transplants were made by surgical microscope-guided direct stereotaxic injection into the ventral horn parenchyma using a mounted 10-KL Hamilton microsyringe and a stainless steel needle with a 10-to 12-bevel angle. The total injection volume was 2 KL that contained~500 neurospheres/KL with 10 to 300 cells/sphere, as determined microscopically before transplantation. The 2-KL volume was delivered in 4 injections made in a raster pattern bilaterally along the anterior-posterior axis of the lumbar spinal cord. To minimize leakage of cells from the injection site, the needle was left in place for 5 minutes before it was withdrawn slowly over 2 minutes. For controls, mSOD1 mice (n = 23) were injected with 200 ng of purified recombinant GFP (Roche), PBS, or GFP tg mouse OB neurospheres subjected to repetitive cycles of freeze-thaw to destroy cell viability. Mice with grafts did not receive immunosuppression with cyclosporin A because tg GFP and SOD1 mice are inbred and have similar genetic backgrounds, cyclosporin A can block neuronal death (27) , has neuroprotective effects in mSOD1 mice (28) , and can also cause CNS toxicity particularly to oligodendrocytes (29) . Five days before killing, the retrograde neuronal tract tracer Fast Blue (2%) was injected at multiple sites in hindlimb muscles or in sciatic nerve of mice with transplants.
Clinical Outcome Measurements
Functional and behavioral assessments were done on mSOD1 mice with and without OB-NPC therapy and on nontg mice. Mice were measured for weight gain as a global index of health. Disease onset was defined as the time at which the body weight of mSOD1 was decreased for a second consecutive time. Mice were evaluated for motor activity using a voluntary running wheel (Mini Mitter Company, Bend, OR) over 24-hour intervals. Hindlimb strength, assessed by the ability of the mouse to maintain its position on a board that is raised in 5-increments, was measured on the inclined plane task (30, 31) . On this test, the maximum angle at which the mouse can maintain its position for a minimum of 5 seconds constituted the score. Mice were tested weekly, starting at 80 days of age, on running wheel and inclined plane tests. Three trials were conducted.
Tissue Harvesting
Mice with GFP tg OB-NPC neurosphere grafts were killed at 40 days after transplantation (110 days of age) (n = 6) or at~125Y135 days of age (n = 6) or were allowed to survive until end-stage disease (n = 15). Mice at end-stage disease did not die spontaneously but were killed. Mice were identified as reaching end-stage disease when they required critical care due to quadriplegia, inability to eat or drink, and cardiorespiratory instability. In our colony, control mSOD1 mice without treatment reach end-stage disease with remarkable concordance (25) . The mSOD1 mice that did not have viable transplants or had recombinant GFP injections, serving as controls for mSOD1 mice with GFP tg OB-NPC neurosphere transplantations, were allowed to survive until 110 days of age (n = 4) or end-stage disease (n = 12). mSOD1 mice that received grafts of wtSOD1 OB-NPC neurospheres transduced with lentivirus-GFP were killed at 40 days after transplantation (110 days of age) (n = 4) or were allowed to survive until end-stage disease (n = 12 mice). Similarly, mSOD1 mice that received transplantations of mSOD1 OB-NPC neurosphere transduced with lentivirus-GFP were killed at 40 days after transplantation (110 days of age) (n = 4) or were allowed to survive until end-stage disease (n = 12 mice). Control mSOD1 mice for mice with wtSOD1 or mSOD1 OB-NPC neurosphere grafts received injections PBS and were allowed to survive until end-stage disease (n = 11). For tissue harvesting mice were anesthetized deeply and perfused transcardially with saline and then 4% PF for fluorescence microscopy or 4% PF plus 0.1% glutaraldehyde for electron microscopy. Spinal cords were sectioned with a microtome or a Vibratome at a thickness of 40 Km.
Immunohistochemistry
Immunohistochemistry was used to characterize the fate of transplanted neurospheres from adult GFP tg mice and adult wtSOD1/mSOD1 tg mice in the spinal cord of mSOD1 mice. Choline acetyltransferase (ChAT) was used as a marker for MNs (20) . Calcium-binding protein calbindin-D28 was used as a marker for spinal interneuron Renshaw cells (32) . GFAP and the glutamate transporter excitatory amino acid transporter-2 (EAAT2) (33) were used as markers for astrocytes. O4 and myelin basic protein (MBP) were used for oligodendrocyte markers (34) . Major histocompatability class (MHC) class II alloantigens were used to detect microglia. Neurofilament protein was used as a marker for axons. Synaptophysin was used as a marker for synapses. The primary antibodies used, except for the EAAT2 (33), were from commercial sources: goat polyclonal anti-ChAT IgG (Chemicon International), rabbit polyclonal anti-GFAP IgG (Dako), mouse monoclonal anti-MBP IgG (SMI-99; Sternberger Monoclonals, Lutherville, MD), mouse monoclonal anti-O4 IgM (Chemicon International), mouse monoclonal anti-neurofilament IgG (SMI-32; Sternberger Monoclonals), mouse monoclonal anti-synaptophysin IgG (Roche), and rat monoclonal antimouse MHC class II alloantigens (BD Pharmingen, San Jose, CA). The sections were processed as described (20) . Secondary antibodies or avidin was conjugated to Alexa 594 or Texas Red (Invitrogen). Double labeling was done using primary antibodies from different species of animals or different immunoglobulin subtypes. Controls for antibody specificity were done for each antibody by incubating sections in the primary antibody diluent with purified IgG isotypes at the same concentration as the corresponding primary antibody. Tissue sections were viewed using Zeiss Axiophot epifluorescence and LSM 410 confocal microscopes. All observations made by epifluorescence microscopy were confirmed by using confocal microscopy that included analysis in the z-axis.
Neuromuscular Junction Staining
After perfusion with PF, the extensor digitorum longus and the soleus muscles were dissected carefully, cryoprotected overnight in 20% glycerol, and sectioned at 40 Km on a freezing microtome. NMJs were visualized with Alexa 594-conjugated >-bungarotoxin (Invitrogen). Sections were analyzed using an LSM 410 confocal microscope. Positive controls were muscles from tg mice with YFP driven by a Thy-1 promoter. MN axons in muscle were visualized by the presence of GFP or YFP.
In Situ Polymerase Chain Reaction
In situ polymerase chain reaction (PCR) was used to identify transplanted cells harboring the GFP gene. Spinal cord sections (40 Km) from mice with or without GFP-OB neurosphere transplants were digested for 5 minutes with proteinase K (10 Kg/mL, room temperature). The sections were rinsed with sterile water and then transferred to a PCR reaction vial with 30 pmol forward and reverse primers, 10x biotinylated dNTP mix (1 mM dATP, 1 mM dGTP, 1 mM dCTP, 0.65 mM dTTP, 0.35 mM biotin-16-dUTP, and 1% bovine serum albumin), 10x Taq reaction buffer, 1 KL of Taq, and H 2 O. The primers were GFP forward (5 ¶-AAGTTCATCTGCACCACCG-3 ¶) and GFP reverse (5 ¶-TCCTTGAAGAAGATGGTGCG-3 ¶). The reaction was run for 30 cycles of denaturation, annealing, and extension at 95, 59, and 72-C, respectively, for 1 minute each. The reaction was terminated with TE buffer. Biotin labeling of nuclei was visualized with the ABC method using cobalt-diaminobenzidine (DAB) as chromogen. Sections were then dual-labeled for GFP using a rabbit polyclonal antibody to GFP (Chemicon International) and immunoperoxidase visualization of immunoreactivity with DAB and nickel-cobalt-DAB.
Immunoelectron Microscopy
To assess the structural integration of transplanted OBNPCs into the spinal cord of mSOD1 mice, immunoelectron microscopy (EM) was used to visualize GFP. Mice with spinal cord transplants were prepared for pre-embedding immuno-EM using immunoperoxidase or immunogold methods as described previously (33, 35) in different preparations. Both approaches were used to identify GFP with high sensitivity (immunoperoxidase) or high cellular resolution (immunogold). Vibratome sections were processed for GFP localization using a rabbit polyclonal antibody to GFP (Chemicon International) as described (20) . Antibody binding sites were visualized with an ABC kit and DAB or with colloidal gold-conjugated secondary antibody followed by silver enhancement. Sections were mounted temporarily on slides and viewed microscopically. Areas of spinal cord containing GFP immunoreactivity were microdissected, and samples were processed and viewed by EM as described previously (35) .
Cell Counting
The numbers of GFP + cells, double-labeled cells with GFP and cell markers, and surviving MNs were counted in mice with and without transplants. Profile counting was used for the cell counting. Cells were counted in a 1 in 10 series of 40-Km-thick sections through the entire lumbar and cervical spinal cord. Generally, about 10 to 12 sections were counted for each mouse.
Statistical Analyses
All data are presented as mean T SD. Comparisons among group values were made using 1-way analysis of variance (ANOVA). When the calculated F value of the ANOVA indicated significance, the Newman-Keuls multiple range test was used. The level of statistical significance was set at p G 0.05. The degree of freedom was 5 to 9.
RESULTS
Adult Mouse OB Neurospheres Are Multipotent
OB core cells from adult wt mouse were isolated, cultured, and evaluated for neurosphere-forming potential. OB core NSC/progenitors readily formed 3-dimensional aggregates of viable self-adherent cells known as neurospheres (Fig. 1A) . Immunocytochemistry confirmed the multipotency of OB neurospheres. Neurospheres were transferred to coated wells and were allowed to attach to the plate but were not allowed to differentiate fully so that the general shape of the sphere could still be discerned. Within this time frame, spheres from some clones attached and issued neurites. These attached neurospheres were generally small (Fig. 1A) , ranging in size from 5 to 100 cells and not differentiated fully because the cultures were evaluated only 3 days after neurosphere attachment. Adult mouse OB core neurospheres are considerably smaller than adult rat OB core neurospheres under comparable culture conditions (19Y21). Individual mouse OB core-derived neurospheres gave rise to cells with distinct morphologies that expressed GFAP (Fig.  1B, E) , class II A-tubulin (Fig. 1C, E) , and O4 (Fig. 1D, E) , thus fulfilling a cardinal feature of a neurosphere (36) . GFAP + cells usually had numerous smooth, thin, fibrous, and highly branching processes (Fig. 1B) . Tuj1 + cells were large, broad, and angular or multipolar and had long processes (Fig. 1C, 
inset, E). O4
+ cells had an immature morphology with a splayed cytoplasm and globular or beaded processes (Fig. 1D, left inset) or a mature morphology with O4 staining decorating the surface of the cell body and their long thin processes (Fig. 1D, right inset) . The former morphology of OB neurosphere-derived oligodendrocytes is very similar to the morphology of immature oligodendrocytes seen in the fetal forebrain (37) . Examination of more than 50 attached OB-derived neurospheres revealed that all were tripotent under the culture conditions described here. Neurosphere multipotency was not influenced by cyropreservation, cryorecovery, and increased passage number studied so far beyond 9 passages. Values are mean T SD. Activity was reduced significantly (**, p G 0.01) in control mSOD1 mice without transplants (n = 11) compared with wild-type (wt) nontransgenic (non-tg) mice (n = 10). Activity in mSOD1 mice with transplants (n = 15) was significantly greater (*, p G 0.05) compared with control mSOD1 mice but significantly lower (*, p G 0.05) than that in wild-type non-tg mice. Mice were tested at 110 days of age. (B) mSOD1 mice with OB-NPC transplants in the spinal cord showed significant improvement on the incline plane test compared with control mSOD1 mice. Values are mean T SD. Angle score was reduced significantly (**, p G 0.01) in control mSOD1 mice without transplants (n = 11) compared with wt non-tg mice (n = 10). The angle score in mSOD1 mice with transplants (n = 15) was increased significantly (*, p G 0.05) compared with control mSOD1 mice but was significantly lower (*, p G 0.05) than that in wt non-tg mice. Mice were tested at 110 days of age. (C) Loss of body weight at 110 days of age was lessened in mSOD1 mice with OB-NPC transplants. Values are mean T SD. Control mSOD1 mice without transplants (n = 7) had significantly lower weight (**, p G 0.01) compared with wt non-tg mice (n = 10). mSOD1 mice with OB-NPC transplants in the spinal cord (n = 14) had significantly increased body mass compared with control mSOD1 mice (*, p G 0.01). (D) OB-NPC transplants in the spinal cord of mSOD1 mice prolonged survival. mSOD1 mice with OB-NPC transplants (n = 15) or without OB-NPC transplants (n = 12) were allowed to survive until end-stage disease at which time they were killed. The percentage of surviving mice in each group is plotted against age at time of death. With control mSOD1 mice 
Adult OB-NPC Grafts Improve Motor Function in mSOD1 Mice
ALS mice with GFP tg OB-NPC transplants or without viable transplants were tested in the running wheel ( Fig. 2A) and on the inclined plane (Fig. 2B) . Wt non-tg mice at 110 days of age registered activities of~200 rotations/hour over a 24-hour test period ( Fig. 2A) . In contrast, mSOD1 mice at 110 days of age without treatment had a significant reduction (p G 0.01) in activity of G50 rotations/hour. With an average of~115 rotations/hour, 110-day-old mSOD1 mice that were recipients of adult OB-NPC transplants showed a significant (p G 0.05) improvement in running activity compared with control mSOD1 mice, although it was significantly lower (p G 0.05) than that in wt mice ( Fig. 2A) . When assessed on the inclined plane test (Fig. 2B) , wt non-tg mice maintained body position for at least 5 seconds at a maximum angle of 65-. The maximum angle for mSOD1 mice without grafts was reduced significantly (p G 0. 01) to 30- (Fig. 2B ). mSOD1 mice with OB-NPC transplants had significant (p G 0.05) improvements on the inclined plane test compared with mSOD1 mice without transplants (Fig. 2B ).
OB-NPC Grafts Attenuate Wasting and Prolong Survival of mSOD1 Mice
Body wasting is a prominent feature in ALS mice (Fig. 2C) . Disease onset assessed by weight loss was similar in mSOD1 mice with grafts (76 T 5 days) compared with mSOD1 mice without transplants (74 T 4 days). At 110 days of age, mSOD1 mice without transplants weighed 40% less than age-matched non-tg mice (Fig. 2C) . The loss of weight was attenuated significantly in 110-day-old mSOD1 mice with GFP tg OB-NPC transplants (Fig. 2C) .
Adult GFP tg OB-NPC grafts extended disease duration and prolonged survival of ALS mice. The average duration of disease (onset to death) in the mSOD1 mouse group without grafts was 52.4 T 8.1 days (mean T SD) versus 74.7 T 15.8 days in the mSOD1 mouse group with grafts. mSOD1 mice that received OB-NPCs had a slower development of motor function deficits about 1 month later than control mSOD1 mice without transplants (at~117 days for grafted mice versus~90 day for control mice), as assessed by a decline in hindlimb function on the inclined plane test. The maximum lifespan of treated mSOD1 mice was about 1 month longer than that of untreated mSOD1 mice (Fig. 2D ), which were killed generally around 137 days of age because of severe paralysis and wasting.
Adult OB-NPC Engraft and Differentiate Into Neurons, Astrocytes, and Oligodendrocytes After Transplantation into ALS Mouse Spinal Cord
Histologic evaluation of mSOD1 mice showed that transplanted neurospheres from GFP tg mice were dispersed completely (i.e. no intact spheres were seen) by 30 days after delivery into the lumbar spinal cord, and many individual GFP + cells were found bilaterally in the ventral horn gray matter (Fig. 2E ) and were detected even at levels of cervical spinal cord (Fig. 3J, right inset) . In mice at 30 days after transplantation the dispersed GFP + cells had differentiated into large multipolar cells with many processes (Figs. 2E, upper inset, 3A), bipolar cells (Fig. 3J) , and smaller glial-like cells (Figs. 2E, lower inset, 3D, G) . Adult OB neurosphere-forming cells were then evaluated for their ability to become cells of different neural lineages after transplantation into mSOD1 mice (Fig. 3) . Transplanted adult GFP tg OB-NPCs in the ALS mouse spinal cord survived (Fig. 2E) and differentiated into neurons and glial cells (Fig. 3) . Different types of GFP + cells had distinct morphologies (Fig. 3A, D, G, J) . GFP + cells ventral to the central canal were counted in every fourth horizontal section (40 Km) of spinal cord. In mice with transplants, significant numbers of GFP + cells were found in the lumbar spinal cord, and, although much fewer in number, GFP + cells were seen in cervical spinal cord (Fig. 3J) . GFP + cells were observed in every section of lumbar spinal cord with numbers achieving 466 T 42 cells/section (mean T SD). At cervical levels, there were 21 T 12 GFP + cells/section (mean T SD) that were usually G10 Km in diameter. The estimated survival of transplanted OB-NPCs in the lumbar spinal cord was~9.0% to 10.8%, determined from an estimated number of 620,000 cells that was delivered into the lumbar spinal cord. GFP + cells were not observed in other organs of mice with transplants, including . In these cells (uppermost inset, arrow) the GFP was seen as aggregates within the cell body (asterisk identified nucleus). Dual labeling for the GFP gene (using in situ polymerase chain reaction [PCR]) and GFP (using immunodetection with diaminobenzidine) revealed evidence for gene silencing in transplanted cells. See M for quantification. Some cells had robust immunolabeling for GFP and were positive for the GFP gene (solid arrows, brown is protein immunodetection, blue/purple is gene detection, and black is overlapping chromogens). A strongly double-labeled cell (in the lowermost inset) has a nucleus (asterisk) that is black due to the presence of both GFP gene and immunoreactivity and the cytoplasm is brown due to GFP immunoreactivity only. skeletal muscle, heart, and liver, indicating that transplanted cells do not emigrate from the CNS. Green cells fluorescing at 488 nm were not observed in control mSOD1 mice. Cells derived from transplanted OB neurospheres were seen as small cells (G10 Km in diameter) and as larger cells (>10 Km in diameter). Subsets of transplanted OB-NPCs in the spinal cord adopted a large multipolar morphology, suggestive of a MN cell type by 30 days after transplantation (Fig. 2E, upper inset) , consistent with a differentiation time frame seen in previous studies of grafted adult mouse OBNPCs into rat spinal cord (20) . A subset of large GFP + cells in lumbar spinal cord was positive for the MN marker ChAT (Fig. 3AYC) . Surviving endogenous MNs were not GFP + (Fig. 3AYC) . About 30% of the GFP + cells observed in the lumbar spinal cord of mSOD1 mice were ChAT + (Fig. 3J) . GFP + cells in cervical spinal cord were not ChAT + . Other subsets (~15%) of OB-NPCs in the spinal cord adopted astroglial morphologies and expressed GFAP (Fig. 3DYF) . OB-neurosphere cells also differentiated into O4 + cells, many of which had the appearance of oligodendrocytes not differentiated fully (Fig. 3GYI) . About 5% of GFP + cells were positive for O4 (Fig. 3J) . A similar proportion of GFP + cells was positive for the oligodendrocyte marker MBP (data not shown).
The cell bodies of many large MN-like cells were labeled incompletely for GFP (Fig. 3L, inset) , leading to our suspicion of GFP gene silencing in some transplanted differentiating OB-NPCs from GFP tg mice. In situ PCR was done to determine whether GFP gene silencing occurs in transplanted OB-NPCs. Some cells were strongly positive for both GFP gene and GFP immunoreactivity (Fig. 3L, lower inset, M) . In situ PCR confirmed the presence of cells positive for the GFP gene but negative for GFP immunoreactivity (Fig. 3L, dashed  arrows) . Approximately 50% of the surviving transplanted cells had silenced GFP gene expression or were in the process of gene silencing as indicated by the sparse GFP immunoreactivity (Fig. 3L, middle inset, M) .
Neurons Derived from Grafted Adult OB-NPCs Integrate into ALS Mouse Spinal Cord
Large GFP + cells integrated into the spinal cord neural network as demonstrated by immunofluorescence and immuno-EM. Synaptophysin + presynaptic boutons contacted GFP + cell bodies directly (Fig. 3K) . Immuno-EM detection of GFP was used to assess ultrastructurally the integration of cells derived from transplanted OB-neurospheres (Fig. 4) . Limited immunoperoxidase reactions (Fig. 4AYD, G, F) or immunogold (Fig. 4F ) was used in separate preparations to localize GFP immunoreactivity discretely within cell bodies and in the neuropil. The GFP immunoperoxidase reaction product was localized discretely as focal deposits within the cytoplasm of neuronal cell bodies (Fig. 4A, inset) , dendrites (Fig. 4A, D) , axons (Fig. 4A, C) , and nerve terminals (Fig. 4A, B) or was localized throughout the cytoplasm and processes of astrocytes (Fig. 4G, H) . Immunogold labeling for GFP was localized as individual particles or clusters of particles within cytoplasm or was associated with organelles ( Fig. 4F) . Control sections processed similarly showed no reaction product or precipitate in cell bodies or processes (Fig. 4E) . Neuronal cell bodies that were derived from transplanted OB-NPCs were GFP + and were contacted by synaptic terminals that were GFP j or GFP + (Fig. 4A, B, F) . Neurons derived from transplanted OB-NPCs formed dendrites contacted by host presynaptic terminals (Fig. 4A, F , upper inset). Neurons derived from transplanted cells also formed axons that were myelinated (Fig. 4A, C) and nerve terminals that formed synaptic contacts with host dendrites (Fig. 4B ) and neuronal cell bodies (Fig. 5A, B) . Transplanted OB-NPCs also differentiated into astrocytes (Fig.  4G) . These astrocytes extended processes that interdigitated among synaptic terminals and dendrites (Fig. 4H) .
ChAT + spinal MNs in mSOD1 mice received afferent innervation from neurons derived from transplanted OBNPCs. Immunofluorescence revealed that subsets of ChAT + MNs were contacted by GFP + boutons (Fig. 5A, D) . Subsequent immuno-EM for GFP showed that host spinal neurons, some of which showed evidence for mitochondrial degeneration as described before (25), were contacted by en passage synaptic terminals of transplant-derived neurons (Fig. 5B) . Immunofluorescence visualization of the astrocyte glutamate transporter EAAT2 showed that large GFP + MN-like cells were surrounded by EAAT2 labeling at their surface (Fig. 5C ) and that endogenous MNs were enshrouded partially by transplanted NPC-derived astroglial processes expressing EAAT2 (Fig. 5D) , consistent with the EM observations showing NPC-derived astrocyte processes effectively interdigitating throughout the spinal cord neuropil (Fig. 4H) . These findings prompted an investigation of the survival of MNs in mSOD1 mice that received transplants of adult OB-NPCs. mSOD1 mice with transplants were killed at the same ages as littermate control mSOD1 mice without OB-NPC grafts that reached end-stage disease. mSOD1 mice without transplants had a 60% loss of lumbar MNs at end-stage disease (Fig. 5E) . In age-matched littermate mSOD1 mice with OB-NPC grafts the loss of MNs was attenuated to 32% (Fig. 5E ). When these mice reached end-stage disease~12% of remaining MNs were GFP + .
Neurons Derived From Grafted Adult OB-NPCs Grow Axons and Project into Peripheral Nerve in ALS Mice but Have Distal Axonopathy and Fail to Occupy Neuromuscular Junctions
Neurons in spinal cord that were derived from transplanted adult GFP tg OB-NPCs grew axons. These axons were seen in the ventral horn gray matter (Fig. 6A ) and ventral root exit zones (Fig. 6B) of the lumbar spinal cord of mSOD1 mice. Green fluorescent axons were not seen in control mSOD1 mice. These observations prompted an examination of the extension of axons derived from transplanted OB cells into peripheral nerve and the innervation of skeletal muscle. The sciatic nerve was evaluated in cross-section for the presence of GFP + axons. Subsets of neurofilament + axons were GFP + in the sciatic nerve (Fig. 6C) . Injection of the retrograde tracer Fast Blue into hindlimb skeletal muscle failed to yield GFP + retrogradely labeled neurons in the lumbar spinal cord of mSOD1 mice. However, when the sciatic nerve of mSOD1 mice with transplants was exposed to Fast Blue, retrogradely labeled neurons were seen in lumbar spinal cord (Fig. 6DYF) . Approximately 45% of the large GFP + MN-like cells projected into peripheral nerve. The absolute number of retrogradely labeled lumbar MNs ranged from 250 to 300 cells/mouse. The failure to label GFP + cells with a retrograde tracer injection into muscle, despite the presence of GFP + axons in the sciatic nerve, suggested an axonal problem located distally. Therefore, the NMJ was evaluated. In naive tg mice with neuron expression of YFP, MN axons are detected discretely in skeletal muscle and at distal sites they precisely innervate the NMJ (Fig. 6G, inset) . In mSOD1 mice with GFP tg OB-NPC transplants, axons of GFP + neurons were observed distally within the skeletal muscle, but these axons were swollen and dystrophic and did not occupy NMJs (Fig. 6G) .
Adult OB-NPC Transplants From tg Mice Expressing Human wtSOD1 and mSOD1 Prolong Survival of mSOD1 Mice and Differentiate into Motor Neuron-Like Cells, Interneurons, and Glial Cells
Neurosphere-forming cells isolated from the OB core of adult mSOD1 mice retain NSC-like characteristics in vitro (21) . Furthermore, adult OB core neurosphere-forming . Presynaptic axon terminal identified by * is shown at higher magnification (inset). This neuron is likely to be a host neuron because of the presence of mitochondrial swelling. Scale bar = 1 Km. (C) Immunofluorescence localization of excitatory amino acid transporter-2 (EAAT2) (red) demonstrates that some transplant-derived large GFP + MN-like cells (green cell labeled 1) have their cell membrane surface invested (open arrows, yellow labeling) by surrounding EAAT2 neuropil staining. Nearby large cell (labeled 2) that is GFP j is surrounded by EAAT2 labeling appearing as red (dotted arrows), whereas another cell (labeled 3) that is GFP + has no yellow labeling at its surface indicating no contact with EAAT2 structures. Scale bar = 3 Km. (D) GFP and EAAT2 (red) colocalize in the lumbar spinal cord neuropil of mSOD1 mice with GFP tg OB-NPC transplants. GFP + cell (asterisk) issues elaborately ramifying processes within the neuropil that colabel with EAAT2 (open arrows, yellow) in the vicinity of a large GFP j cell (seen as a negative image because of the rich EAAT2 immunoreactivity) likely to be an endogenous MN (cell identified as 1). GFP j large cells (identified as 1 and 2) are contacted by GFP + boutons (dotted arrows, see also A). Scale bar = 7 Km. (E) Counts of MNs in lumbar spinal cord in wild-type (wt) nontransgenic (non-tg) mice, mSOD1 mice without OB-NPC grafts, and mSOD1 mice with OB-NPC transplantations (n = 6 mice/group). Values are the mean T SD of the number of MNs per cresyl violet-stained section. The MN number in control mSOD1 mice was significantly lower (**, p G 0.01) than that for wt mice. The MN number in mSOD1 mice with grafts was significantly greater (*, p G 0.05) than that for control mSOD1 mice but significantly lower (*, p G 0.05) than that for wt non-tg mice. Counts were done on mice at 125 to 137 days of age at which time control in SOD1 mice achieved endstage disease, whereas mice with OB-NPC grafts were age-matched but not at end-stage disease. Copyright @ 200 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. cells overexpressing human wtSOD1 have enhanced NSClike characteristics in vitro and in vivo (21) . Therefore, we evaluated the regenerative potential of tg neurospheres from adult wtSOD1 and mSOD1 mice when grafted into the spinal cord of mSOD1 mice. Neurosphere-forming cells from wtSOD1 and mSOD1 tg mice were transduced with a GFP reporter by lentiviral-mediated gene transfer (Fig. 7A) . The onset of mortality (Fig. 7B ) of mSOD1 mice with wtSOD1 OB-NPC transplants was delayed considerably (between 125 and 130 days) compared with that of control mice (between 100 and 105 days). This delay in the onset of death seen in mSOD1 mice with wtSOD1 OB-NPC transplants was greater than that seen in mSOD1 mice with GFP tg OB-NPC neurosphere transplants (Fig. 2D) . Maximal survival of ALS mice was also prolonged significantly by wtSOD1 OB-NPC transplants (Fig. 7B) but was not much different from that seen with GFP tg neurosphere transplants (Fig. 2D ). mSOD1 mice with mSOD1 OB-NPC transplants had an early disease course similar to that of control mice; however, disease progression was slower than that of control mice but was faster than that of mice with wtSOD1 OB-NPC transplants (Fig. 7B) . The maximum lifespan was prolonged by about 10 days in mSOD1 mice with mSOD1 OB-NPC transplants compared with control mice (Fig. 7B) .
Grafted neurosphere-forming NPCs from tg wtSOD1 and mSOD1 mouse OB cores were then evaluated for their ability to become cells of different neural and non-neural lineages in mSOD1 spinal cord. All transplanted neurospheres dispersed completely in mSOD1 mouse spinal cord. Subsets of wtSOD1 and mSOD1 NPCs differentiated into large, ChAT + , multipolar neurons (Fig. 7CYE ) and into astrocytes (Fig. 7FYH) and microglia (Fig. 7IYK ) by 30 days after transplantation. wtSOD1 neurosphere cells also differentiated into subsets of spinal interneurons, as identified by calbindin (Fig. 7LYN) , which marks Renshaw cells (32) .
DISCUSSION
These experiments demonstrate the neuroregenerative benefits of transplanted adult OB-NPCs in a mouse model of ALS. We show that adult OB-NPCs have the potential to become neurons with features of MNs, interneurons, and glia after transplantation into the spinal cord of mSOD1 mice. The transplanted cells integrate structurally into the host spinal cord-peripheral nerve network and can retard MN degeneration, improve motor function, delay the onset of disease, and prolong survival of mice with ALS.
We used neurosphere-forming cells isolated from adult mouse OB core for cell therapy in mSOD1 mice. In culture, OB neurosphere-forming cells express nestin, self-renew for extended periods, and produce vast progeny that can differentiate to the 3 types of neural cells (19, 20) , thus meriting the designation of NSC based on original definitions of CNS-NSCs (38) and neurosphere cells (36) . However, nestin is expressed also in multipotent progenitor cells (39) , and neurosphere formation is not an exclusive property of NSCs because progenitor cells can also form neurospheres (26) . Thus, we identified these cells as proliferative, multipotent NPCs rather than as true NSCs to be conservative.
One possible mechanism underlying the ability of adult OB-NPCs to exert beneficial effects is replacing cells that are damaged or degenerated and lost. In ALS mice, MNs, spinal interneurons, and possibly astrocytes degenerate (24, 25, 40) . It is unclear whether oligodendrocytes degenerate in ALS mice, but in human ALS demyelination of the corticospinal tracts is prominent (41) . We show that subsets of grafted adult OB-NPCs adopt phenotypes of MNs, interneurons, and astrocytes in mSOD1 mouse spinal cord. Some transplanted OB-NPCs also differentiate into O4/ MBP + cells typical of oligodendrocytes. The ability of transplanted OB-NPCs to differentiate into different cell types in spinal cord occurred by 30 days after transplantation. This finding is consistent with data showing that most adult-generated OB neurons attain a fully mature morphology between 15 and 30 days after birth. These observations support a cell replacement mechanism and are consistent with previous in vivo data on the multipotency of transplanted adult OB-NPC neurospheres. In an adult rat peripheral nerve avulsion model, mouse OB neurosphereforming cells engrafted into spinal cord, dispersed effectively, survived, differentiated into neurons, astrocytes, and oligodendrocyte/astrocyte precursors, and integrated structurally into the adult host neural network (20) .
Transplanted adult OB-NPCs also could exert therapeutic effects in ALS mice by providing afferent synaptic support or cell-mediated protection of endogenous MNs Grafts of wtSOD1 and mSOD1 OB-NPC neurospheres into the spinal cord of mSOD1 mice at preclinical stages of the disease (70 days of age) prolonged survival of diseased mice. Lentiviral-GFP transduced OB-NPC neurospheres from human wtSOD1 and mSOD1 tg mice were transplanted into the lumbar spinal cord of mSOD1 mice (n = 12 for each neurosphere genotype), and mice were allowed to survive until end-stage disease at which time they were killed. Controls were mSOD1 mice subjected to sham surgery (n = 11). The percentage of surviving mice in each group is plotted against age at time of death. In the control group there were 10 of 11, 7 of 11, and 1 of 11 survivors at 110, 120, and 130 days of age, respectively. mSOD1 mice with tg mSOD1 OB-NPC neurosphere against excitotoxicity or oxidative stress. We show that neurons derived from transplanted OB-NPCs innervate host MNs. Specifically, ChAT + MNs were contacted by axosomatic synaptic boutons made by neurons derived from OBNPCs. The targeting of these axon terminals to MN soma and the robust axonal arborization, revealed by the numerous GFP + axons with EM, suggested that some grafted cells might differentiate into inhibitory interneurons, consistent with the natural ability of OB-NPCs to become GABAergic or glycinergic interneurons (42) . This suspicion was confirmed by observing that subsets of transplanted OB-NPCs differentiate into inhibitory spinal interneurons (Renshaw cells) identified by calbindin. A loss of spinal interneurons (25) and reduced glycinergic innervation of MNs (43) occurs before MN loss in ALS mice. These deficits could be counteracted by OB-NPC replacement of spinal interneurons. Transplanted OB-NPCs also formed EAAT2 glutamate transporter-expressing astrocytes with processes that intermingled with host terminals and dendrites; moreover, transplanted OB-NPCs differentiated into microglial cells, which would signify the capacity for transdifferentiation as seen before with the ability of OB-NPCs to become muscle cells (20) . Thus, new cells derived from lumbar implants of NPCs could help sustain or protect endogenous MNs and extend their survival as supported by our data showing more endogenous MNs in midsymptomatic ALS mice with transplants than in ALS mice without transplants. The lumbar implants improved mobility so that mice can sustain better feeding/drinking behavior.
This idea of transplanted cell-mediated protection of MNs relates to the theory that MN degeneration in ALS mice is not cell autonomous (44) but involves other cell types such as microglia (45) . Microglial cells expressing mSOD1 could propagate disease (45) , whereas wt microglia and astrocytes could offer protection (44, 46) . Grafted OB-NPCs derived from GFP and wtSOD1 tg mice both had major lifespan-extending effects. The SOD1 genotype of these transplanted cells was either non-tg wt (GFP tg) or human wtSOD1 tg. Tg human wtSOD1 neurospheres had the greatest effects. Their differentiation into glia would be consistent with the idea that wt astroglial and microglial cells can extend the survival of mSOD1 mice (44, 46) . Transplanted OBNPCs derived from mSOD1 mice also had modest positive effects, and they also differentiated into glial cells. Thus, newly generated and differentiated cells expressing mSOD1 do not appear to be inherently toxic over a short term because outcome was not worsened. Cell aging over the entire lifespan could be necessary for mSOD1 protein to acquire its toxicity in vivo. The lesser benefit offered by transplanted adult NPCs expressing mSOD1 is consistent with the observation that they have compromised potential (21) .
Our experiments are different in design from those of most publications on transplantation of NSCs or NPCs. We delivered adult neurospheres derived from tg mice expressing GFP, human wtSOD1, or human mSOD1 into the spinal cord of mSOD1 mice. Very few published experiments have been done using neurospheres derived from adult brain for transplantation in spinal cord injury and disease models. Other transplantation work has been done using fetal tissue (47) , dissociated embryonic SCs (10, 48) , human NSCs (11), human umbilical cord blood SCs (12, 13) , human embryonic germ cell derivatives (10), fetal hippocampal neurospheres (49), or bone marrow SCs (14) . One other group has used adult SVZ region-derived neurospheres containing multipotent NPCs in a mouse model of multiple sclerosis (15, 16) . They showed that adult NPCs differentiate into oligodendrocyte precursors and myelinforming cells in spinal cord (15) . Transplanted neurospheres also have immunomodulation effects (16) , which could be relevant to our findings in mSOD1 mice. Here we show that transplanted adult mouse OB-NPC neurospheres can differentiate into neurons and glia in ALS mice. The molecular mechanisms regulating the ability of adult OB-NPCs to differentiate into these different types of cells after transplantation in adult spinal cord are not known.
The observation that adult OB-NPCs can differentiate in vivo into neurons with phenotypes of MNs distinguishes our data from the results of other studies. Transplanted human embryonic SCs, NSCs, embryonic germ cells, umbilical cord SCs, and bone marrow SCs have very limited or no capacity for differentiation into cells with MN-like characteristics in traumatically injured or diseased spinal cord (10Y14). Regarding the cells we used, these NPCs originate from the anterior SVZ, migrate within the rostral migratory stream and OB core, and then invade the more superficial OB where they mature into local GABAergic periglomerular interneurons and granule neurons (50) . Most of these interneurons are short-axon cells, but some send interglomerular axons over very long distances (51) . Thus, OB core neurospheres might be particularly advantageous for use in transplantation into damaged/diseased adult CNS because of their partial NPC composition and derivation from a neural system known for ongoing neurogenesis, neuronal migration, local axon outgrowth, and interneuron differentiation within adult CNS (22) . Our in vivo results were foreshadowed by other in vivo experiments and in vitro data. In a model of MN degeneration induced by nerve avulsion (20) , transplanted adult mouse OB-NPC neurospheres differentiated into ChAT + , multipolar MN-like cells and oligodendrocytes in the avulsed spinal cord but not in nonlesioned spinal cord, indicating that the loss of MNs and axonal degeneration are required to specify differentiation of NSC/NPCs into MN and oligodendrocyte phenotypes. Adult OB-NSCs and -NPCs in coculture with embryonic striatal neurons differentiate into GABAergic neurons and in coculture with skeletal myoblasts differentiate into ChAT + and acetylcholinesterase + , large, multipolar neurons that form NMJs (19, 20) .
The cells in spinal cord derived from grafted OB neurospheres integrate into the host neural network. The experiments showed that transplant-derived neurons formed axons that could be myelinated (see Fig. 4A , dashed arrows, C), axon terminals that formed synapses with endogenous neurons, and dendrites that were contacted by host presynaptic terminals. Such data on the ultrastructural integration of SC-derived neurons after transplantation into the nervous system is critical but shown very rarely. Nevertheless, we have not yet conducted experiments to determine whether these OB neurosphere-derived MN-like cells are functional neurons determined electrophysiologically. Although the ultrastructural analysis verified the structural integration of transplanted OB-NPCs, it also generated concern. We observed a surprising affinity for synaptic interaction among the neurons derived from the OB-NPCs. It is not clear whether these connections are normal or aberrant. Further evidence for integration was gleaned from tracing studies. These experiments revealed the extraordinary finding that some newly generated spinal neurons grow axons into the peripheral nerve of ALS mice, but they became dystrophic and failed to innervate skeletal muscle. These observations are very important for 2 reasons. Inherent mechanisms tend to retard axon outgrowth within the adult CNS, but axonal growth in the adult peripheral nervous system can be achieved. Transplanted NSCs and NPCs in the spinal cord thus must overcome the CNS barrier to axon outgrowth; however, OB-NPCs have mechanisms to grow axons in the adult CNS and integrate into a preexisting neural network (42) , and if this can be achieved in spinal cord, axon growth in the peripheral nervous system is known to be possible. The mechanism allowing adult OB-NPCs to grow local axons might be related to the presence of specific disintegrin and metalloproteases (52) . The failure to elaborate full neuromuscular integration might be due to insufficient time for establishment of NMJs, distal axonopathy, or an inability to form junctions due to skeletal muscle toxicity of mSOD1.
These preclinical findings are relevant to the development of cell-based therapies for human ALS. The adult human OB contains resident NSC/NPCs (19, 53) . Thus, the OB in the human brain is a potential target for manipulations, designed to recruit endogenous NPCs or to transplant syngeneic wt cells or autologous cells for sporadic ALS (or autologous engineered cells with corrected SOD1 for familial ALS), with the goal of replacing upper and lower MNs in patients with ALS. However, translating this approach into the clinic presents major hurtles. Harvesting multipotent NPCs from the human OB is invasive, and the human OB is less accessible than the rodent OB. However, neurosurgical approaches are established for exposing the human OB and are used for olfactory grove meningiomas and OB tumors (54Y56). A unilateral biopsy of the OB might cause mild disability such as hemianosmia, but, when faced with the fatal paralysis of ALS, such an approach might be welcomed. A complication of intraspinal NSC/NPC transplantation seen in animal models is allodynia (57) . However, one study in human patients with ALS has shown that intraspinal autologous mesenchymal SCs are safe and well tolerated (6) . Nevertheless, our work suggests that the spinal cord microenvironment is damaging to the ability of the new cells to exert sustained effects, whether through replacement of cells or by nurturing of endogenous MNs. Cell therapies might be more sustained with coadministration of pharmaceutical agents targeting disease mechanisms.
